Clinical Trials Sponsored by Gustave Roussy Cancer Campus Grand Paris

Total 258 results

Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Study Evaluating Near-infrared Imaging Coupled With Indocyanine Green for Intraoperative Control of Resection Margins in ENT Surgery (MAGNOLIA)

Head and Neck Cancer

Belgium, France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

USE OF 18FDG PET-CT TO PREDICT THE RESPONSE OF MANDIBULAR OSTEORADIONECROSIS TO THE PENTOCLO PROTOCOL WITH DOCUMENTED ANTIBIOTHERAPY (PENTOTEP)

Mandibular Osteoradionecrosis

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma (HIPANIV)

Hepatocellular Carcinoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) (HR-NBL2)

High-Risk Neuroblastoma | Patient With Insufficient Response Chemoimmunotherapy

France, Germany, Israel, Spain, United Kingdom, Belgium, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Denmark, Greece, Lithuania, Slovakia
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs (PREMIS)

Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma (ADJORL1)

Head and Neck Squamous Cell Carcinoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Prognostic and Predictive Biomarkers in Ovarian Cancers (OvBIOMark)

Ovarian Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Trial Of Pembrolizumab And Nintedanib (PEMBIB)

Patients With Any Advanced Solid Tumors

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma (SEMITEP)

Seminoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours (SABR-PDL1)

Patients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma )

France
Gustave Roussy, Cancer Campus, Grand Paris

Suspended

Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors (ARIANES)

Solid Tumor

France
Gustave Roussy, Cancer Campus, Grand Paris

Suspended

Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (NIRADO)

Clear Cell Renal Cell Carcinoma | Head and Neck Cancer | Gastric Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Biliary Tract Cancer | Urothelial Bladder Cancer | Gastro-oesophageal Adenocarcinoma | Platinum-sensitive Urothelial Bladder Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Pasireotide to Reduce Clinically Relevant Digestive Leakage After Complete Cytoreductive Surgery (CRS) Plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis (PASIREOCHIP)

Peritoneal Carcinomatosis

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99) (ALCL 99)

Lymphoma

France, Spain, Italy, Belgium, Germany, Switzerland, Austria, United Kingdom, Netherlands, Sweden
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults (VINILO)

Refractory Low-grade Gliomas | Recurrent Low-grade Gliomas

Austria, Italy, France, Denmark, Netherlands, Spain, Switzerland, United Kingdom
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma (LMS04)

Uterine or Soft Tissue Leiomyosarcoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer (MERAIODE)

Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome) (LIFSCREEN)

Li Fraumeni Syndrome

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years

Metastatic, Cerebral Primitive Neuroectodermal Tumors

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Molecular Screening for Cancer Treatment Optimization (MOSCATO 02)

Metastatic Solid Tumors (Any Localization)

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Video-Based Cognitive Behavioral Therapy for Insomnia in Adults Cancer Patients and Survivors (SLEEP-4-ALL)

Insomnia

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Multiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot Study (IMAHTEP)

NSCLC

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies (SKINTARGET)

Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Neurocognitive Risks in Children With Solid Tumors (RISK-N)

Solid Tumor in Children

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics (CAPRI)

Metastatic Cancer | Hematological Malignancy

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Prospective Study Assessing Thyroidectomy Using Robot (EVATAR)

Patients With Thyroid Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Local Treatment by Thermic Destruction of Primitive Breast Cancer (LASERBREAST1)

Breast Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes (CSET 1437)

Non Small Cell Lung Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Robot Assisted Mastectomy Via Axillary Way With Areola Conservation and Immediate Reconstruction (MARCI)

Breast Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population

Oral Cavity Cancer | Oesophageal Cancer | Pharynx Cancer | Larynx Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab (IIPOP)

Patients With Gastric Peritoneal Carcinomatosis

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases Melanoma (ILP+/-IPI)

In-transit Metastases Melanoma Stage IIIB and IIIC

France
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma (Mel-Ipi-Rx)

Malignant Melanoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast (VARIA-DCE-US)

GIST Metastatic Cancer | Breast Metastatic Cancer | Kidney Metastatic Cancer | Colon Metastatic Cancer | Rectal Metastatic Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Transpulmonary Thermodilution Using an Implented Central Venous Access Port (ThermoD-PAC)

Medical Oncology

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate Cancer (FIBROP)

Prostate Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer (BEAUTY)

Breast Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer

STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents

Glioma

France, United Kingdom
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Treatment of Mature B-cell Lymphoma/Leukaemia

B-Cell Lymphoma

France, United Kingdom, United States
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma

Malignant Brain Tumor | Brain Stem Glioma,

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck

Carcinoma, Adenoid Cystic | Cancer of the Head and Neck

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood

Neuroectodermal Tumors, Primitive | Medulloblastoma | Brain Tumors

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle

Sarcoma of Pelvis

France
Gustave Roussy, Cancer Campus, Grand Paris

Suspended

Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients

Prostate Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Glivec Phase II Pediatric Study

Cancer

France, United Kingdom, Netherlands
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse

Neoplasms, Connective and Soft Tissue | Osteosarcomas | Medulloblastomas | Rhabdomyosarcomas | Ewing Tumor | Neuroblastomas

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area

Recurrence of Head and Cancer in Irraiated Area

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE.

LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE UCNT

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Radiofrequency Ablation of Lung Tumors

Lung Cancer | Metastasis

France

Clinical Trials Sponsored by Gustave Roussy Cancer Campus Grand Paris

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations